The Brazilian Health Regulatory Agency received a temporary authorization request for the Chinese immunizer Sinopharm. It has not undergone clinical trials in Brazil but has been tested in countries like the United Arab Emirates, Egypt, Argentina, and Peru.
LATEST NEWS
- UAE among target markets for 40 tech companies
- Embraer’s order backlog hits record
- Syrian Club to screen Tunisian film on Palestine
- Qatar to host Intercontinental Cup finals
- Sudan clears imports of more Brazilian products
- Event highlights opportunities in the Arab world
- Dubai in wood: The art of Francisco Suelo
- Passenger numbers rise on flights in Brazil

